Summary of findings: Comparison 3 ‐ deferiprone (DFP) vs deferasirox (DFX)
SAEs
It is very uncertain whether summary of findings: Comparison 3 ‐ deferiprone (DFP) changes total SAEs compared with deferasirox (DFX) (very low certainty).
1 finding from 1 review
- Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia 2023 · Cochrane Headline outcomes onlyRR 0.95 [0.46, 1.96]1 study · 390 participantsVery low